204 related articles for article (PubMed ID: 29744254)
21. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
22. Differential Expression of MicroRNAs in Leprosy Skin Lesions.
Soares CT; Trombone APF; Fachin LRV; Rosa PS; Ghidella CC; Ramalho RF; Pinilla MG; Carvalho AF; Carrara DN; Soares FA; Belone AFF
Front Immunol; 2017; 8():1035. PubMed ID: 28970833
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-Responsive Mir-301a and Mir-301b Promote Radioresistance of Prostate Cancer Cells via Downregulating NDRG2.
Wang W; Liu M; Guan Y; Wu Q
Med Sci Monit; 2016 Jun; 22():2126-32. PubMed ID: 27327120
[TBL] [Abstract][Full Text] [Related]
24. Gga-miR-130b-3p inhibits MSB1 cell proliferation, migration, invasion, and its downregulation in MD tumor is attributed to hypermethylation.
Zhao C; Li X; Han B; Qu L; Liu C; Song J; Lian L; Yang N
Oncotarget; 2018 May; 9(36):24187-24198. PubMed ID: 29849932
[TBL] [Abstract][Full Text] [Related]
25. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
[TBL] [Abstract][Full Text] [Related]
26. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
[TBL] [Abstract][Full Text] [Related]
27. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C
Microrna; 2019; 8(1):68-75. PubMed ID: 30073936
[TBL] [Abstract][Full Text] [Related]
28. Screening of Differently Expressed miRNA and mRNA in Prostate Cancer by Integrated Analysis of Transcription Data.
Sun Y; Jia X; Hou L; Liu X
Urology; 2016 Aug; 94():313.e1-6. PubMed ID: 27179774
[TBL] [Abstract][Full Text] [Related]
29. [Hypermethylation of miR-107, miR-130b, miR-203a, miR-1258 Genes Associated with Ovarian Cancer Development and Metastasis].
Loginov VI; Burdennyy AM; Filippova EA; Pronina IV; Kazubskaya TP; Kushlinsky DN; Ermilova VD; Rykov SV; Khodyrev DS; Braga EA
Mol Biol (Mosk); 2018; 52(5):801-809. PubMed ID: 30363055
[TBL] [Abstract][Full Text] [Related]
30. Identification of reciprocal microRNA-mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis.
Ma H; Wang LY; Yang RH; Zhou Y; Zhou P; Kong L
J Cell Biochem; 2019 Oct; 120(10):17779-17790. PubMed ID: 31127646
[TBL] [Abstract][Full Text] [Related]
31. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
[TBL] [Abstract][Full Text] [Related]
32. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-induced microRNA-301b regulates apoptosis by targeting Bim in lung cancer.
Wu D; Chen B; Cui F; He X; Wang W; Wang M
Cell Prolif; 2016 Aug; 49(4):476-83. PubMed ID: 27352910
[TBL] [Abstract][Full Text] [Related]
34. A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
Basu S; Majumder S; Bhowal A; Ghosh A; Naskar S; Nandy S; Mukherjee S; Sinha RK; Basu K; Karmakar D; Banerjee S; Sengupta S
PLoS One; 2015; 10(5):e0125560. PubMed ID: 25938433
[TBL] [Abstract][Full Text] [Related]
35. Human tumor microRNA signatures derived from large-scale oligonucleotide microarray datasets.
Wang W; Peng B; Wang D; Ma X; Jiang D; Zhao J; Yu L
Int J Cancer; 2011 Oct; 129(7):1624-34. PubMed ID: 21128228
[TBL] [Abstract][Full Text] [Related]
36. Bioinformatics identification of potentially involved microRNAs in Tibetan with gastric cancer based on microRNA profiling.
Luo Y; Zhang C; Tang F; Zhao J; Shen C; Wang C; Yu P; Wang M; Li Y; Di JI; Chen R; Rili G
Cancer Cell Int; 2015; 15():115. PubMed ID: 26692821
[TBL] [Abstract][Full Text] [Related]
37. microRNA Expression Profiling in Young Prostate Cancer Patients.
Valera VA; Parra-Medina R; Walter BA; Pinto P; Merino MJ
J Cancer; 2020; 11(14):4106-4114. PubMed ID: 32368293
[TBL] [Abstract][Full Text] [Related]
38. Circulating miRNA Expression Profiling and Target Prediction in Patients Receiving Dexmedetomidine.
Yang X; Chen H; Chen Y; Birnbaum Y; Liang R; Ye Y; Qian J
Cell Physiol Biochem; 2018; 50(2):552-568. PubMed ID: 30308506
[TBL] [Abstract][Full Text] [Related]
39. Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling.
Xiang S; Chen H; Luo X; An B; Wu W; Cao S; Ruan S; Wang Z; Weng L; Zhu H; Liu Q
J Exp Clin Cancer Res; 2018 Aug; 37(1):184. PubMed ID: 30081934
[TBL] [Abstract][Full Text] [Related]
40. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
